for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Akari Therapeutics announces FDA fast track designation for Coversin

March 30 (Reuters) - Akari Therapeutics Plc

* Akari Therapeutics announces FDA fast track designation for Coversin

* Akari Therapeutics Plc says is evaluating coversin in two Phase 2 clinical trials Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up